555 related articles for article (PubMed ID: 31983222)
1. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
Toepfer CN; Garfinkel AC; Venturini G; Wakimoto H; Repetti G; Alamo L; Sharma A; Agarwal R; Ewoldt JK; Cloonan P; Letendre J; Lun M; Olivotto I; Colan S; Ashley E; Jacoby D; Michels M; Redwood CS; Watkins HC; Day SM; Staples JF; Padrón R; Chopra A; Ho CY; Chen CS; Pereira AC; Seidman JG; Seidman CE
Circulation; 2020 Mar; 141(10):828-842. PubMed ID: 31983222
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of force-pCa relation in
Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
[TBL] [Abstract][Full Text] [Related]
3. A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations.
Cohn R; Thakar K; Lowe A; Ladha FA; Pettinato AM; Romano R; Meredith E; Chen YS; Atamanuk K; Huey BD; Hinson JT
Stem Cell Reports; 2019 Jan; 12(1):71-83. PubMed ID: 30554920
[TBL] [Abstract][Full Text] [Related]
4. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation.
Witjas-Paalberends ER; Ferrara C; Scellini B; Piroddi N; Montag J; Tesi C; Stienen GJ; Michels M; Ho CY; Kraft T; Poggesi C; van der Velden J
J Physiol; 2014 Aug; 592(15):3257-72. PubMed ID: 24928957
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies.
Yotti R; Seidman CE; Seidman JG
Annu Rev Genomics Hum Genet; 2019 Aug; 20():129-153. PubMed ID: 30978303
[TBL] [Abstract][Full Text] [Related]
6. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
7. Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction.
Kinnear C; Said A; Meng G; Zhao Y; Wang EY; Rafatian N; Parmar N; Wei W; Billia F; Simmons CA; Radisic M; Ellis J; Mital S
Cell Rep Med; 2024 May; 5(5):101520. PubMed ID: 38642550
[TBL] [Abstract][Full Text] [Related]
8. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.
Green EM; Wakimoto H; Anderson RL; Evanchik MJ; Gorham JM; Harrison BC; Henze M; Kawas R; Oslob JD; Rodriguez HM; Song Y; Wan W; Leinwand LA; Spudich JA; McDowell RS; Seidman JG; Seidman CE
Science; 2016 Feb; 351(6273):617-21. PubMed ID: 26912705
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin.
Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D
J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247
[TBL] [Abstract][Full Text] [Related]
10. Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.
Kraft T; Montag J
Pflugers Arch; 2019 May; 471(5):719-733. PubMed ID: 30740621
[TBL] [Abstract][Full Text] [Related]
11. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.
Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA
Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic cardiomyopathy mutations in
Toepfer CN; Wakimoto H; Garfinkel AC; McDonough B; Liao D; Jiang J; Tai AC; Gorham JM; Lunde IG; Lun M; Lynch TL; McNamara JW; Sadayappan S; Redwood CS; Watkins HC; Seidman JG; Seidman CE
Sci Transl Med; 2019 Jan; 11(476):. PubMed ID: 30674652
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.
Ramachandra CJA; Kp MMJ; Chua J; Hernandez-Resendiz S; Liehn EA; Knöll R; Gan LM; Michaëlsson E; Jonsson MKB; Ryden-Markinhuhta K; Bhat RV; Fritsche-Danielson R; Lin YH; Sadayappan S; Tang HC; Wong P; Shim W; Hausenloy DJ
Cardiovasc Res; 2022 Jan; 118(2):517-530. PubMed ID: 33705529
[TBL] [Abstract][Full Text] [Related]
14. Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes.
Alamo L; Ware JS; Pinto A; Gillilan RE; Seidman JG; Seidman CE; Padrón R
Elife; 2017 Jun; 6():. PubMed ID: 28606303
[TBL] [Abstract][Full Text] [Related]
15. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
16. Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.
Wijnker PJM; van der Velden J
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165774. PubMed ID: 32217077
[TBL] [Abstract][Full Text] [Related]
17. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
[TBL] [Abstract][Full Text] [Related]
18. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
Nakashima Y; Kubo T; Sugiura K; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kimura A; Doi YL; Kitaoka H
Circ J; 2020 Sep; 84(10):1846-1853. PubMed ID: 32830170
[TBL] [Abstract][Full Text] [Related]
19. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
Lakdawala NK; Olivotto I; Day SM; Han L; Ashley EA; Michels M; Ingles J; Semsarian C; Jacoby D; Jefferies JL; Colan SD; Pereira AC; Rossano JW; Wittekind S; Ware JS; Saberi S; Helms AS; Cirino AL; Leinwand LA; Seidman CE; Ho CY
Circ Genom Precis Med; 2021 Feb; 14(1):e003062. PubMed ID: 33284039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
